Department of Cell and Developmental Biology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
* Author for correspondence (e-mail: turnerce{at}upstate.edu)
Accepted 3 August 2005
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Cell migration, Actin cytoskeleton, Focal adhesion, Crk, Tyrosine phosphorylation, Hic-5
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The focal adhesion adaptor protein paxillin has been shown to be intricately involved in linking both scaffolding and signaling molecules from sites of integrin and growth factor receptor engagement to the internal actin cytoskeleton (Rozengurt, 1995; Turner, 2000
; Turner et al., 1990
). Furthermore, paxillin is essential for embryonic development (Hagel et al., 2002
) and the elevated levels of paxillin tyrosine phosphorylation are probably important in facilitating cell migration and tissue remodeling within the developing embryo (Turner, 1991
; Turner, 2000
).
Paxillin is a 68 kDa phosphoprotein originally identified as a substrate for the non-receptor tyrosine kinase Src in Rous sarcoma virus-transformed fibroblasts (Glenney and Zokas, 1989; Turner et al., 1990
). Structurally, paxillin consists of an N-terminal region containing five LD protein-protein interaction motifs, a proline-rich region possibly involved in Src-SH3 binding, the SH2 binding phosphotyrosine residues 31 and 118; and a C-terminal region containing four LIM domains that are responsible for focal adhesion targeting and binding to the phosphotyrosine phosphatase PTP-PEST and the microtubule protein tubulin (Brown et al., 1998a
; Brown et al., 1996
; Cote et al., 1999
; Herreros et al., 2000
; Schaller and Parsons, 1995
; Tumbarello et al., 2002
; Turner, 2000
).
Functionally, paxillin has been implicated in the regulation of cell adhesion, spreading and motility, muscle differentiation and gene expression through its ability to directly interact with multiple structural and signaling proteins involved in coordinating these events, such as tubulin, p120RasGAP, PKL, PTP-PEST, FAK, Src, Crk and Csk (Brown et al., 1996; Cote et al., 1999
; Herreros et al., 2000
; Sabe et al., 1994
; Schaller and Parsons, 1995
; Tsubouchi et al., 2002
; Turner et al., 1999
). Importantly, paxillin Y31 and Y118 phosphorylation mediates the interaction with Crk and p120RasGAP (Schaller and Parsons, 1995
; Tsubouchi et al., 2002
). These interactions are associated with cytoskeletal regulation through modulation of the Rho GTPases, Rac1 and RhoA respectively, and appear to perform cell specific roles in regulating integrin signaling and migration (Lamorte et al., 2003
; Petit et al., 2000
; Tsubouchi et al., 2002
). Importantly, both RhoA and Rac1 activity are implicated in actin cytoskeletal remodeling during EMT owing to their involvement in the dissociation of cell-cell adhesion and the formation of cell-ECM adhesion (reviewed by Lozano et al., 2003
; Savagner, 2001
).
A larger paxillin superfamily exists that includes the paralogues Hic-5/Ara55 (Fujimoto et al., 1999; Shibanuma et al., 1994
; Thomas et al., 1999
) and leupaxin (Lipsky et al., 1998
). These proteins maintain the general structure of paxillin with well-conserved N-terminal LD motifs and C-terminal LIM domains (Tumbarello et al., 2002
). Interestingly, a growing literature purports a role for Hic-5 as a natural antagonist of paxillin function presumably by virtue of its capacity to quench signaling through paxillin by competition with shared LD-binding partners, PTP-PEST (Nishiya et al., 1999
) and GIT1 (Nishiya et al., 2002
), and through suppression of signaling downstream of paxillin tyrosine phosphorylation (Nishiya et al., 2001
).
Three paxillin isoforms, , ß and
produced by alternative splicing have been described (Mazaki et al., 1997
; Turner and Miller, 1994
). Interestingly, examination of the paxillin nucleotide sequence (Turner and Miller, 1994
) reveals an internal AUG codon with a conserved Kozak sequence present downstream of the primary start codon (Kozak, 1987
). Subsequent cloning of paxillin cDNAs from multiple species including human, mouse, frog, zebrafish and fly reveal that this downstream `alternative' translation site is evolutionarily conserved.
Herein, we provide evidence for the existence of a truncated form of paxillin which is produced from an internal translation initiation site within the full-length paxillin mRNA. The internally translated form of paxillin , named paxillin
to conform to current nomenclature, differs in its N-terminal region by lacking the LD1 domain, the proline-rich region, and the SH2-binding tyrosine residues at amino acid positions 31 and 118. Paxillin
protein is preferentially expressed in a well-differentiated epithelium, whereas expression is reduced following transforming growth factor ß1 (TGF-ß1)-induced transition to a mesenchymal phenotype. In contrast, Hic-5 exhibits a reciprocal protein expression profile. Paxillin
localizes efficiently to focal adhesions where it can suppress the tyrosine phosphorylation of full-length paxillin
, implicating it as a possible negative regulator of integrin signaling. Indeed forced protein expression of paxillin
inhibited cell migration in normal murine mammary gland (NMuMG) epithelial cells, whereas overexpression of Hic-5 stimulated cell migration. Finally, evidence is presented indicating that tyrosine phosphorylation of paxillin during TGF-ß1-induced EMT in NMuMG cells promotes an interaction with the adapter protein Crk, rather than p120RasGAP. We suggest that paxillin
protein expression in epithelial cell populations serves as an internal competitive inhibitor of integrin signaling through full-length paxillin
to limit inappropriate trans-differentiation and cell migration as occurs during epithelial cell metastasis.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Plasmids
Avian paxillin cDNA constructs were cloned into pcDNA3.1 (Invitrogen). Full-length paxillin plasmid with an internal Kozak mutation was generated by site-directed mutagenesis utilizing an oligonucleotide (5'-GAACCATCTCCCTCACTGACCAGCACC-3') for the insertion of two site-specific nucleotide mutations introducing the amino acids serine at position 132 and leucine at position 133. The paxillin plasmid, starting from methionine residue 133 of the avian paxillin cDNA, was generated by PCR and sequenced in its entirety. The pEGFPc1 vector was used in cotransfection studies for the identification of the transfectants.
Cell culture and transfection
Chinese hamster ovary (CHO.K1) cells were maintained in modified Ham's F-12 (Mediatech) supplemented with 10% (v/v) heat-inactivated, certified FBS (Atlanta Biologicals), 50 U/ml penicillin and 50 µg/ml streptomycin (Sigma-Aldrich). Normal murine mammary gland (NMuMG) cells purchased from ATCC were maintained in Dulbecco's modified Eagle's medium (Mediatech) supplemented with 10% (v/v) heat-inactivated FBS, 1 mM Glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin. Cells were maintained at 37°C in a humidified chamber with 5% CO2. Transfection of CHO.K1 cells was performed with Fugene 6 (Roche Molecular Biochemicals) according to the manufacturer's instructions. For EMT induction of NMuMG cells, 3x105 cells were plated in six-well dishes 24 hours prior to stimulation in complete DMEM, 10% FBS. Cells were either stimulated with vehicle alone (4 mM HCl, 0.1% BSA) or with 2 ng/ml TGF-ß1 for 48 hours.
Retrovirus production and infection
The pLEGFPc1 retroviral vector (BD clontech) was provided by B. Pawlikowski (SUNY Upstate Medical University). XhoI and BamHI restriction sites were generated by PCR flanking the full-length paxillin (containing internal Kozak mutation) (GFP-FLpax), paxillin
and Hic-5 cDNA for subsequent cloning into the pLEGPc1 vector. Production of retroviral supernatant was performed as described on the Nolan Laboratory website (http://www.stanford.edu/group/nolan/). Briefly, Phoenix 293 packaging cells (obtained from B. Pawlikowski, SUNY Upstate Medical University, NY) were transfected with the retroviral constructs by calcium phosphate-mediated transfection followed by collection of retrovirus conditioned media 24-72 hours post-transfection. NMuMG cells, plated in six-well dishes, were infected by treatment with retroviral conditioned media supplemented with 4 µg/ml polybrene (Sigma-Aldrich) followed by centrifugation at 1000 g for 20 minutes at 32°C.
Boyden chamber motility assay
Modified Boyden chamber migration assays were performed as previously described (Riedy et al., 1999). An 8 µm polycarbonate filter (Neuroprobe) was pre-coated with 100 µg/ml gelatin type B (Sigma-Aldrich) at room temperature for 16 hours. Briefly, 10,000 cells were plated in the upper chamber of a Boyden chamber apparatus and the cells were allowed to migrate to 10 µg/ml fibronectin in serum-free media (Sigma-Aldrich) for 16 hours at 37°C. The polycarbonate filter was then fixed in methanol and stained with Giemsa (Sigma-Aldrich). Cells migrating to the underside of the membrane were quantified by obtaining an absorbance value at 540 nm. Values are the mean of three experiments. The migration of the GFP control was set to 100%, and the other cell types were measured against this value. Statistical analysis was performed using Student's t-test.
Collagen gel culture
3D collagen I gels were prepared on ice using equal volumes of Vitrogen 100 (Cohesion) and 2x HEPES-buffered salt solution [50.4 mM HEPES, pH 7.4, 162.6 mM NaCl, 10.6 mM KCl, 88.2 mM NaHCO3, 1.6 mM Na2HPO4, and 11 mM D(+)-glucose] (Saelman et al., 1995) yielding a concentration of 1.3 mg/ml following addition of culture medium. The collagen gel solution (0.7 ml) was added to each 35 mm tissue culture dish and allowed to gel at 37°C for 30 minutes. NMuMG cells were collected in a single cell suspension and resuspended in the collagen gel solution at a concentration of 3x105/ml followed by the addition of 300,000 cells onto the preformed collagen gel. The collagen mixture was allowed to gel at 37°C for 30 minutes before the addition of 1.5 ml culture medium. Culture medium was replenished every 2-3 days until day 7, at which time complex structures had formed. For 2D culture, cells were seeded at 300,000 cells/35 mm tissue culture dish in growth media and were cultured alongside 3D collagen gel cultures. Hoffman modulation contrast microscopy was performed with a Nikon Eclipse TE-300 microscope equipped with a 20x objective lens and a SpotTM RT Monochrome camera (Diagnostic Instruments). The images were processed using SPOTTM RT Software v3.0 (Diagnostic Instruments).
Western blotting and immunoprecipitation
NMuMG cell lysates were prepared in RIPA buffer: 1% NP-40, 0.1% SDS, 1% sodium deoxycholic acid, 150 mM NaCl, 20 mM Tris-HCl pH 7.6, 5 mM EDTA, 1 mM PMSF, 10 µg/ml leupeptin (Sigma-Aldrich), and phosphatase inhibitors (2 mM sodium fluoride, 2 mM sodium pyrophosphate, 1 mM Na3VO4; Sigma-Aldrich). For immunoprecipitation, cell lysates were prepared in lysis buffer: 1% Triton X-100, 0.1% sodium deoxycholic acid, 96 mM NaCl, 10 mM Tris-HCl pH 7.6, 1 mM EDTA, 1 mM PMSF and 10 µg/ml leupeptin. BioRad Dc Protein Assay was performed on cell lysates. For NMuMG detergent-soluble lysates, 25 µg lysate was mixed with an equal volume of 2x SDS-sample buffer. For Pax1 immunoprecipitation, 200-400 µg protein lysate was incubated with the Pax1 antiserum and Protein A/G agarose at 4°C for 1 hour with rotation, followed by washing in lysis buffer. Samples were boiled in SDS sample buffer for 5 minutes prior to being loaded and run on 7.5% SDS-PAGE and transferred to Immobilon NC (Millipore). Western blot analysis was performed as previously described (West et al., 2001).
Coimmunoprecipitation
Prior to cell lysis, cells were washed once with ice-cold PBS. Cells were lysed in 1% Triton X-100, 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 10% Glycerol, 10 µg/ml leupeptin, and phosphatase inhibitors. Cell lysates were centrifuged at 14,000 g for 15 minutes at 4°C. 800-1000 µg cell lysate were utilized for coimmunoprecipitation experiments. Cell lysates were either incubated with 1 µg Crk, p120RasGAP (clone B4F8), paxillin (clone 165) or control IgG (Santa Cruz) antibodies for 2 hours at 4°C followed by the addition of 12.5 µl Protein A/G Agarose (1:1 suspension) for 1 hour at 4°C with rotation. Bead complexes were washed twice with cold lysis buffer and boiled with 2x SDS sample buffer. Western blot analysis was performed as previously described (West et al., 2001).
Respreading assay and immunofluorescence microscopy
For respreading assays, CHO.K1 cells were removed from tissue culture dishes by washing with PBS followed by incubation for 3-5 minutes with PBS supplemented with 1 mM EDTA. Cells were collected and washed twice with Ham's F-12, 10% FBS and once with serum-free Ham's F-12 containing 1% BSA. Cells were resuspended in serum-free media supplemented with 1% BSA and placed on a rocker in suspension for 1 hour at 37°C. Cells were replated on fibronectin-coated coverslips (10 µg/ml) in serum-free media supplemented with 1% BSA and then subsequently processed for indirect immunofluorescence microscopy at the indicated time points as previously described (West et al., 2001). Imaging was performed utilizing a Zeiss Axiophot photomicroscope equipped with epifluorescence illumination using a SPOTTM RT slider camera (Diagnostic Instruments). Images were processed using Adobe PhotoshopTM v6.0.1.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Verification of paxillin as an internal translation product and its localization to focal adhesions
Expression in CHO.K1 cells of the wild-type avian paxillin cDNA (wt pax) containing both the primary and internal Kozak sequences generates two protein products of 68 kDa and 46 kDa as detected with the paxillin-specific monoclonal antibody, PXC10 (Sigma), which recognizes an epitope within the LIM domains (C.E.T., unpublished observations) (Fig. 2A). Both products are also recognized by the paxillin 165 and 349 antibodies (Transduction Labs) (data not shown). Two paxillin protein products, also of 68 and 46 kDa, are produced from the same paxillin cDNA following in vitro transcription/translation (Nikolopoulos and Turner, 2000).
|
The LIM 3 domain of paxillin has previously been shown to be essential for paxillin localization to focal adhesions (Brown et al., 1996). The LIM domains are unaltered in paxillin
. Thus, to confirm that the absence of the N-terminal portion of paxillin (amino acids 1-132) has no detrimental effect on the focal adhesion targeting of paxillin
, exogenous expression studies followed by immunofluorescence microscopy were performed in CHO.K1 cells. Expression of avian paxillin
in CHO.K1 cells followed by staining with the avian-specific anti-paxillin antibody (Pax1) (Turner et al., 1990
), demonstrated robust localization of paxillin
to vinculin-rich focal adhesions (Fig. 2Bc,f), similar to wild-type paxillin (Fig. 2Ba,d). As expected, the full-length paxillin protein, corresponding to paxillin
and derived from the cDNA containing mutations in the internal Kozak region (FL pax KM), also targeted efficiently to focal adhesions (Fig. 2Bb,e).
Expression of paxillin is restricted to epithelial cell types
To further test for the natural occurrence of paxillin , the protein expression profile was examined in a series of cell lines utilizing the paxillin-specific antibody, PXC10 (Fig. 3). Interestingly, although paxillin
(68 kDa) was expressed in all cell lines examined, including those of both mesenchymal (lanes 1-4) and epithelial origin (lanes 5-7), the 46 kDa product corresponding to paxillin
was predominantly expressed only in the epithelial cells, NMuMG, MDCK and NRK. In striking contrast, Hic-5, detected using a Hic-5-specific antibody (Transduction Labs) was primarily expressed in mesenchymal cells (Fig. 3, lanes 1-4). Our results indicate a suppression of Hic-5 protein expression in normal epithelial cells and although Hic-5 mRNA may be present in certain transformed epithelia such as HeLa cells (Zhang et al., 2000
) and in selected prostate cancer cells (Mestayer et al., 2003
), protein expression was not confirmed in these reports. Regardless, our data indicate that paxillin
and Hic-5 exhibit a reciprocal expression pattern in a variety of normal epithelial and mesenchymal cell lines.
TGF-ß1 induction of epithelial-mesenchymal transformation in NMuMG cells modulates paxillin and Hic-5 expression
A natural transition between epithelial and mesenchymal phenotypes (EMT) occurs during tissue remodeling associated with embryonic development, wound repair and during tumor metastasis (Birchmeier and Birchmeier, 1993; Duband et al., 1995
; Thiery, 2002
). We were interested in determining if the reciprocal expression pattern exhibited by paxillin
and Hic-5 could be recapitulated during EMT induced in culture. The murine mammary gland epithelial cell line, NMuMG, can be induced to undergo an EMT when treated with TGF-ß1 (Miettinen et al., 1994
). In the epithelial state, NMuMG cells exhibit a typical `cobblestone' morphology. These cells have relatively few focal adhesions, a cortical arrangement of actin filaments, and there is a substantial cytoplasmic pool of paxillin (Fig. 4Aa,c,e) (Nakamura et al., 2000
). Following stimulation with 2 ng/ml TGF-ß1 for 48 hours, a morphologic change is induced which is characterized by a dissociation of cell-cell contacts and the appearance of a flattened, elongated fibroblastic phenotype in which paxillin is localized predominantly to focal adhesions at the ends of well-organized actin stress fibers (Fig. 4Ab,d,f) (Nakamura et al., 2000
).
|
Consistent with previous reports, the TGF-ß1-induced EMT coincides with the loss of cell-cell adherens junctions and the downregulation and relocalization of E-cadherin to the perinuclear region (Fig. 5A; data not shown). Conversely, N-cadherin is upregulated and becomes localized at the cell membrane (Fig. 5A; data not shown). Biochemical characterization of the paxillin profile during TGF-ß1-induced EMT indicates that full-length paxillin exhibits a substantial upward shift in electrophoretic mobility resulting from multiple phosphorylation events including phosphorylation of Y31 and Y118 (Fig. 5B) (Nakamura et al., 2000
). There may also be a modest increase in protein expression, as reported following TGF-ß1 treatment of malignant astrocytoma cells (Han et al., 2001
). In striking contrast, paxillin
expression is highest when cells are maintained in the epithelial state and is significantly reduced after the TGF-ß1-induced transition to the mesenchymal phenotype (Fig. 5A,B).
|
Paxillin expression is maintained following differentiation of NMuMG cells in a collagen I gel
Culture of epithelial cells in a 3D collagen I gel provides a suitable environment to support the generation of well-differentiated epithelium in the form of spherical cysts and/or tubules (Hall et al., 1982) (reviewed by Zegers et al., 2003
). Previous reports have demonstrated the downregulation of specific focal adhesion proteins, FAK, talin and p130Cas, following the culture of MDCK cells on a collagen I gel and consequently a reduction in integrin-mediated signaling through these proteins (Wang et al., 2003
). We therefore sought to determine if paxillin
was preferentially expressed in cells cultured in a 3D environment, consistent with our predicted role for paxillin
in the maintenance of an epithelial phenotype. NMuMG cells were cultured under normal 2D culture conditions or cultured within collagen I gels. Following a 7-day incubation period, NMuMG cells cultured under 2D conditions exhibit a typical cobblestone-patterned monolayer (Fig. 6Aa), whereas cells grown under 3D conditions form complex structures indicative of cysts and tubules (Fig. 6Ab). The expression profiles of various focal adhesion proteins were assessed by western blot analysis. Interestingly, the expression level of paxillin
was maintained in 3D cultured cells at levels comparable to that detected in cells cultured under 2D conditions (Fig. 6B,C). In striking contrast, the protein expression of other focal adhesion components including vinculin, p130Cas and FAK were significantly decreased (Fig. 6B). Importantly, similar results were obtained utilizing MDCK cells cultured under identical conditions (data not shown).
|
In addition to a reduction in FAK expression, phosphorylation at Tyr397 (an indicator of FAK activity) was correspondingly reduced in the 3D culture conditions, consistent with an attenuation in integrin signaling under these conditions (Fig. 6B). Although paxillin expression remained unchanged, full-length paxillin
expression in cells cultured under 3D conditions was reduced along with a significant reduction in paxillin Y118 phosphorylation, as determined following paxillin immunoprecipitation (Fig. 6C). Immunodetection of paxillin
in the total lysates was not possible with the 3D cultures owing to the presence of large amounts of co-migrating matrix/serum proteins. In accordance with previous reports, the decrease in tyrosine phosphorylation of FAK and paxillin in cells cultured under 3D conditions is not likely to be the result of inefficient extraction of protein (Wozniak et al., 2003
). Paxillin tyrosine phosphorylation is tightly coupled to FAK/Src activity (Turner, 2000
). Thus, the reduction in paxillin phosphorylation in both 2D and 3D cultures provides further evidence for a suppression of this particular axis of the integrin signaling pathway. Furthermore, under 3D culture conditions that more closely resemble the physiologic environment of epithelial tissues by permitting complete cell differentiation, paxillin
expression, in contrast to a number of other focal adhesion proteins including paxillin
, is maintained at a relatively high level. These results further suggest a role for paxillin
in maintaining differentiated epithelia by possibly preventing EMT-associated cell migration through the suppression of integrin signaling to paxillin
.
Paxillin suppression of full-length paxillin phosphorylation in CHO.K1 cells
To evaluate how paxillin may influence normal integrin signaling to paxillin
, exogenous expression studies were performed in CHO.K1 cells. Cells were transiently transfected with either full-length paxillin Kozak mutant (FL pax KM) or paxillin
constructs. Following protein expression, the cells were harvested and then replated on fibronectin to induce cell spreading and thereby integrin signaling (Fig. 7A). At time points ranging from 60 to 240 minutes, overexpression of the FL pax KM construct did not have any significant effect (<12%) on paxillin Y118 phosphorylation in focal adhesions (as measured using a phospho-paxillin Y118 antibody) (Fig. 7Ba,b and C) when compared to vector control (data not shown), consistent with this paxillin construct functioning in an identical fashion to the endogenous protein. In contrast, cells transiently transfected with the paxillin
cDNA showed a substantial reduction in focal adhesion staining for endogenous paxillin Y118 phosphorylation at all time points (Fig. 7Bc,d and C). Similar results were obtained using anti-phospho Y31 antibodies (data not shown). Interestingly, the paxillin
transfectants showed no obvious spreading defect, consistent with previous reports indicating that phosphorylation of Y31 and Y118, although critical for Crk-mediated cell migration in certain cell types (Petit et al., 2000
), is not required for cell adhesion (Brown et al., 1998b
) or cell spreading (Wade et al., 2002
). Unfortunately, antibodies that can discriminate between full-length paxillin and paxillin
are not available. Thus, we were unable to determine whether the loss of phospho-Y118 staining in focal adhesions is due to the exclusion of paxillin
from focal adhesions or potentially due to paxillin
sequestering paxillin-binding proteins such as FAK/Src and thereby abrogating their ability to efficiently phosphorylate full-length paxillin at Y31 and 118 within focal adhesions. Nevertheless, these results clearly demonstrate that paxillin
can suppress integrin signaling to paxillin
.
|
|
The ability of paxillin to suppress integrin signaling to paxillin
in both CHO.K1 and NMuMG cells, as evidenced by reduced paxillin
phosphorylation, along with previously published data regarding the importance of paxillin
phosphorylation in cell migration (Nakamura et al., 2000
; Petit et al., 2000
; Tsubouchi et al., 2002
), suggests a potential role for paxillin
in suppressing a migratory phenotype. Thus, we used Boyden chamber transwell assays to evaluate the impact of paxillin
on cell migration. NMuMG cells overexpressing GFP-pax
exhibited a significant reduction in migration to fibronectin compared to levels in the GFP control and GFP-FL pax expressing cells (Fig. 8D; P<0.001). Importantly, cells overexpressing Hic-5 exhibited a significant stimulation of migration to fibronectin (Fig. 8D; P<0.001). The small reduction in migration seen with the GFP-FL pax overexpressing cells (Fig. 8D; P<0.05) is consistent with previous reports (Yano et al., 2000
). Together these data reinforce the notion that paxillin
may be functioning to preserve an immobile epithelium through a suppression of full-length paxillin tyrosine phosphorylation and Hic-5 expression, and thereby limiting the ability of the cell to migrate in the absence of an appropriate physiologic stimulus.
TGF-ß1-induced paxillin tyrosine phosphorylation leads to elevated levels of Crk binding in vivo
As indicated, paxillin downregulation following TGF-ß1-induced EMT of NMuMG cells correlated with a robust increase in paxillin phosphorylation at Y31 and Y118. In order to delineate the biochemical interactions associated with paxillin following tyrosine phosphorylation, coimmunoprecipitation experiments were performed with NMuMG cells to evaluate the interactions of previously described binding partners. The Y31 and Y118 phosphorylation sites mediate direct associations with the SH2 domains of Crk and p120RasGAP and thereby initiate signaling events associated with actin cytoskeletal remodeling. For instance, in NBT-II bladder carcinoma cells a paxillin-Crk association is essential for migration on collagen (Petit et al., 2000
). In contrast, Sabe and colleagues could not detect this interaction in NMuMG cells and instead suggested that p120RasGAP binding to paxillin contributed to p190RhoGAP-mediated Rho inhibition to promote lamellipodial extension and motility (Tsubouchi et al., 2002
).
To evaluate which of the endogenous paxillin binding proteins is utilized in our model system, a series of coimmunoprecipitation experiments were performed with NMuMG cells cultured under conditions promoting epithelial monolayers or following treatment with TGF-ß1 to induce EMT. Interestingly, Crk is able to coimmunoprecipitate the tyrosine-phosphorylated form of paxillin under both conditions, but the amount of paxillin
precipitated increased following EMT (Fig. 9A) concomitant with the increase in tyrosine phosphorylation. Increased levels of p130CAS and FAK (probably via an indirect association with Cas or paxillin) co-precipitating with Crk were also observed following TGF-ß1 stimulation (Fig. 9A). Of particular note is that the increase in paxillin
association with Crk correlates with the decrease in paxillin
expression (Fig. 9A). Also, owing to the lack of the primary SH2-binding consensus phosphorylation sites on paxillin
, it does not interact with Crk (Fig. 9A).
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In addition to our data demonstrating the regulated expression of paxillin , evidence from others suggests that expression of this 46 kDa paxillin isoform may be regulated in other physiological contexts associated with morphological changes such as those occurring during immune regulation and development. For example, interferon treatment of U937 leukemia cells has been reported to trigger a downregulation of 44-46 kDa paxillin isoforms and concomitant increase in the full-length 68-70 kDa isoforms whereas the opposite is observed with primary monocytes (Surin et al., 2002
). During renal morphogenesis where the requirement for cell migration decreases, full-length paxillin expression has been shown to decrease while expression of a lower molecular weight protein of approximately 46 kDa, recognized by paxillin-specific antibodies, is increased (Sorenson and Sheibani, 1999
). Additionally, it has been reported that the induction of cell-cell adhesion in Ewing's sarcoma cells by MMP-9 siRNA results in an increase in the expression of a 44-46 kDa paxillin product (Sanceau et al., 2003
). In fact, evidence has been provided that the 46 kDa protein could be derived from translation at methionine residue 133 (Wade et al., 2002
). These data support the normal and regulated expression of this new paxillin isoform.
Translational control has long been recognized as a principal means to regulate gene expression and cell function and considerable progress has been made in elucidating the pathways that govern control at the level of internal translation initiation (Sonenberg et al., 2000). The precise mechanism of regulation of paxillin
expression remains to be determined; however, paxillin has a 5'-UTR of over 700 nucleotides with six upstream AUG sequences and is thus categorized as a weak mRNA (Geballe and Morris, 1994
). Weak mRNAs that have complex 5' secondary structure tend to display inefficient translation from the principal translational start and consequently may be outcompeted by strong mRNAs and may also exhibit shunting to a downstream translation start that is less encumbered by secondary structure (Sonenberg et al., 2000
). As the 5' m7G-cap binding translation initiation factor eIF4E is limiting in cells, those mRNAs with complex secondary structure can be outcompeted in ribosome binding (Pelletier and Sonenberg, 1987
). Activation of eIF4E by growth factor stimulation, inactivation of 4E-BP (Gingras et al., 2001
) and/or upregulation of eIF4E, as occurs in many cancers (De Benedetti and Harris, 1999
), can override the inefficiency to effect translation of the upstream start at the expense of the downstream site. In such a manner, paxillin
translation may be regulated as a result of TGF-ß1 stimulation. It is also of interest that paxillin was recently found to interact with the poly(A) binding protein 1 (Woods et al., 2002
) as it has been established that a functional association between the eIF4E/5'-cap RNA structure and the PABP1/3'-poly(A) RNA tail through eIF4G is a mechanism of translational stimulation that may be regulated through derepression of an inhibitory complex (Sonenberg et al., 2000
). Although paxillin
expression may be regulated at the translational level, there exists the possibility that paxillin
has a decreased stability under certain conditions relative to full-length paxillin, thereby causing a decrease in its expression. Further work will be required to determine the mechanism of regulation of paxillin
and Hic-5 expression and whether paxillin may function in a self-regulatory loop.
The expression of isoforms that represent truncated products is an emerging theme associated with signal regulation via focal adhesion proteins. The PKL/GIT2/CAT2 Arf-GAP protein has an alternatively spliced mRNA that generates a truncated product termed KIAA0148/GIT2short that lacks the C-terminal paxillin binding site (Bagrodia et al., 1999; Mazaki et al., 2001
; Premont et al., 2000
; Turner et al., 1999
). Additionally, the CAT2 binding protein, p85Cool-1/ßPix, has an alternatively spliced variant termed p50Cool-1 (Bagrodia et al., 1998
). Intriguingly, Hic-5 exists in two isoforms that are the products of alternative splicing, `full-length' Hic-5 and a product termed ARA55 that lacks the first 17 amino acids, which includes LD1 (Fujimoto et al., 1999
; Shibanuma et al., 2000
; Thomas et al., 1999
). Similarly, alternative splice products of FAK and PYK2, termed FAK-related non-kinase (FRNK) and PRNK, respectively, have been identified and demonstrated to operate as functional antagonists of the `full-length' isoform in the context of integrin signaling (Schaller et al., 1993
; Xiong et al., 1998
).
The generation of a paxillin isoform that lacks well-defined protein binding interfaces and the principle sites of tyrosine phosphorylation but maintains other binding sites and the focal adhesion targeting motif may permit differential signaling as compared to the full-length protein. Paxillin is tyrosine phosphorylated in response to various growth factors such as epidermal growth factor (EGF), angiotensin II and TGF-ß1, as well as in response to integrin engagement during cell migration and adhesion (Burridge et al., 1992
; Nakamura et al., 2000
; Petit et al., 2000
; Riedy et al., 1999
; Turner et al., 1995
). Increased tyrosine phosphorylation of focal adhesion components, including paxillin, has been associated with the transformation of epithelial cells to a more motile and invasive phenotype (Kinch and Burridge, 1995
; Mueller et al., 1992
). Following integrin engagement, phosphorylation of paxillin at distinct SH2-binding YXXP motifs by the FAK-Src complex leads to the recruitment and formation of a variety of adaptor and signaling proteins that are involved in the transduction of signals through specific Rho GTPases, leading to actin cytoskeleton reorganization during cell migration (Nobes and Hall, 1995
; Petit et al., 2000
; Schaller and Parsons, 1995
; Tsubouchi et al., 2002
). In particular, paxillin phosphorylation at Y31 and Y118 by the FAK-Src complex (Schaller and Parsons, 1995
) creates binding sites for the Crk family of adapter proteins, the C-terminal Src kinase, Csk, as well as p120RasGAP (Petit et al., 2000
; Sabe et al., 1994
; Tsubouchi et al., 2002
).
The paxillin Y31 and Y118 residues have been shown to be necessary for Crk-mediated cell migration in NBT-II bladder epithelial cells (Petit et al., 2000) and Crk-mediated lamellipodia formation and cell spreading in MDCK epithelial cells (Lamorte et al., 2003
). Paxillin tyrosine phosphorylation and its association with Crk probably contributes to Rac1 activation via the Crk/DOCK180/ELMO complex to promote the motile phenotype (Gumienny et al., 2001
). Our own results indicate that paxillin tyrosine phosphorylation also promotes association with Crk in the NMuMG cell line, in contrast to an earlier study using these cells, which indicated that Y31- and Y118-phosphorylated paxillin preferentially binds p120RasGAP thereby facilitating cell migration through an inhibition of RhoA activity (Tsubouchi et al., 2002
). The authors proposed that this is accomplished by the association of paxillin with p120RasGAP causing a dissociation of p190RhoGAP from p120RasGAP and a resultant activation of p190RhoGAP. However, contradictory evidence has suggested that phosphorylated p190RhoGAP associated with p120RasGAP is the active form of p190RhoGAP (Noren et al., 2003
). Regardless of the mechanism of RhoGAP activation, we were unable to detect any association between paxillin and p120RasGAP and no effect on the interaction between p120RasGAP and p190RhoGAP despite the TGFß1-induced paxillin tyrosine phosphorylation in NMuMG cells. Thus, as reported in other epithelial cell model systems, a regulated Crk association with paxillin is likely to play a critical role in the regulation of morphology and motility in NMuMG cells. Although the reason for the discrepancy between our own results and the other NMuMG studies is unclear, the difference could be attributed to cell-specific differences as a number of clonal lines exhibiting a variety of phenotypes have been derived from the parental NMuMG population (Soriano et al., 1995
; Zutter et al., 1999
).
Although our results may indicate that the primary role of paxillin is its suppression of full-length paxillin signaling mediated through the SH2-binding tyrosine residues, another important distinction between full-length paxillin and paxillin
is the loss of the LD1 protein interaction motif. The paxillin LD1 motif has been shown to mediate interactions with the actin-binding protein actopaxin and the serine/threonine integrin-linked kinase, ILK (Nikolopoulos and Turner, 2000
; Nikolopoulos and Turner, 2001
). Actopaxin is involved in the regulation of the actin cytoskeleton during the processes of cell adhesion and motility (Nikolopoulos and Turner, 2000
; Tu et al., 2001
); whereas ILK has been implicated in the regulation of cell growth, fibronectin-matrix assembly, cell adhesion and EMT (Hannigan et al., 1996
; Nikolopoulos and Turner, 2001
; Somasiri et al., 2001
; Wu et al., 1998
). Overexpression of ILK in the intestinal epithelial cell line, IEC-18, leads to the downregulation of E-cadherin and the production of an organized fibronectin matrix, which are characteristic of a mesenchymal phenotype (Wu et al., 1998
). Overexpression of ILK in a mammary epithelial cell line, scp2, has also been directly linked to changes characteristic of a transition to a mesenchymal phenotype (Somasiri et al., 2001
), which may be related to the capacity of ILK to induce an active LEF-1/ß-catenin complex (Novak et al., 1998
; Persad et al., 2001
). Expression of paxillin
in epithelial cells may regulate the localization and functional activity of actopaxin and ILK providing an additional mechanism for regulation of cytoskeleton reorganization and the repression of a motile phenotype.
Although several reports have detailed the capacity of Hic-5 overexpression to antagonize paxillin function in cell spreading and motility (Nishiya et al., 1999; Nishiya et al., 2001
) the NMuMG epithelial cell line does not necessarily conform to this paradigm. First, paxillin is primarily cytosolic in a hypophosphorylated form and Hic-5 is undetectable when these cells are cultured as an epithelium (Fig. 4). Induction of an EMT by stimulation with TGF-ß1 resulted in a robust stimulation of paxillin localization to focal adhesions and an increase in tyrosine phosphorylation, concurrent with a dramatic induction of Hic-5, robust focal adhesion localization and a substantial reduction in paxillin
expression (Figs 4 and 5). In addition, overexpression of paxillin
inhibited paxillin
tyrosine phosphorylation during adhesion and spreading on fibronectin (Fig. 7) as well as during TGF-ß1-induced EMT in NMuMG cells (Fig. 8A,B). Furthermore, introduction of a scratch wound into a monolayer of NMuMG cells triggers a rapid increase in Hic-5 expression and colocalization with induced tyrosine phosphorylated paxillin in focal adhesions at the leading edge (D.A.T. and C.A.T., unpublished observations). Finally, this report demonstrates, for the first time, a proactive role for Hic-5 in stimulating cell migration. Whether this occurs via a parallel or alternative signaling pathway with respect to full-length paxillin remains to be determined. Together, these results suggest a role for paxillin
as the primary physiologic competitor to paxillin-mediated integrin signaling in NMuMG cells, with Hic-5 performing a more complementary role to full-length paxillin. Interestingly, a role for Hic-5 as a specific transcriptional coactivator of the Fos gene has also been described (Kim-Kaneyama et al., 2002
). Induction or overexpression of Fos can promote events such as tumorigenesis, metastasis and EMT (Hay, 1995
; Reichmann et al., 1992
) in part through LEF-1/ß-catenin (Kim et al., 2002
). That observation, combined with our demonstration that Hic-5 is upregulated during the process of TGF-ß1-induced EMT provides a potential functional context for Hic-5 regulation during EMT.
The more global role of paxillin as a functional antagonist to full-length paxillin, the possible interrelationship with Hic-5 and the role for these proteins in EMT that occurs during processes such as organism and tissue development, wound repair and tumor metastasis awaits further investigation. The presence of a new paxillin isoform independently translated from the primary paxillin transcript increases the complexity and reinforces the importance of the paxillin adaptor protein family in organizing signaling events originating from focal adhesions during cell migration and adhesion.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Bagrodia, S., Taylor, S. J., Jordon, K. A., Van Aelst, L. and Cerione, R. A. (1998). A novel regulator of p21-activated kinases. J. Biol. Chem. 273, 23633-23636.
Bagrodia, S., Bailey, D., Lenard, Z., Hart, M., Guan, J. L., Premont, R. T., Taylor, S. J. and Cerione, R. A. (1999). A tyrosine-phosphorylated protein that binds to an important regulatory region on the cool family of p21-activated kinase-binding proteins. J. Biol. Chem. 274, 22393-22400.
Birchmeier, C. and Birchmeier, W. (1993). Molecular aspects of mesenchymal-epithelial interactions. Annu. Rev. Cell Biol. 9, 511-540.[CrossRef][Medline]
Birchmeier, C., Birchmeier, W. and Brand-Saberi, B. (1996). Epithelial-mesenchymal transitions in cancer progression. Acta Anat. 156, 217-226.[Medline]
Boyer, B., Valles, A. M. and Edme, N. (2000). Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol. 60, 1091-1099.[CrossRef][Medline]
Brown, M. C., Perrotta, J. A. and Turner, C. E. (1996). Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J. Cell Biol. 135, 1109-1123.[Abstract]
Brown, M. C., Curtis, M. S. and Turner, C. E. (1998a). Paxillin LD motifs may define a new family of protein recognition domains. Nat. Struct. Biol. 5, 677-678.[CrossRef][Medline]
Brown, M. C., Perrotta, J. A. and Turner, C. E. (1998b). Serine and threonine phosphorylation of the paxillin LIM domains regulates paxillin focal adhesion localization and cell adhesion to fibronectin. Mol. Biol. Cell 9, 1803-1816.
Burridge, K., Turner, C. E. and Romer, L. H. (1992). Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol. 119, 893-903.[Abstract]
Cote, J. F., Turner, C. E. and Tremblay, M. L. (1999). Intact LIM 3 and LIM 4 domains of paxillin are required for the association to a novel polyproline region (Pro 2) of protein-tyrosine phosphatase-PEST. J. Biol. Chem. 274, 20550-20560.
De Benedetti, A. and Harris, A. L. (1999). eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31, 59-72.[CrossRef][Medline]
Duband, J. L., Delouvee, A., Rovasio, R. A. and Thiery, J. P. (1982). Mechanism of avian crest cell migration and homing. Prog. Clin. Biol. Res. 85, 497-508.[Medline]
Duband, J. L., Monier, F., Delannet, M. and Newgreen, D. (1995). Epithelium-mesenchyme transition during neural crest development. Acta Anat. 154, 63-78.[Medline]
Fujimoto, N., Yeh, S. and Chang, C. (1999). Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 274, 8316-8321.
Geballe, A. P. and Morris, D. R. (1994). Initiation codons within 5'-leaders of mRNAs as regulators of translation. Trends Biochem. Sci. 19, 159-164.[CrossRef][Medline]
Giancotti, F. G. and Ruoslahti, E. (1999). Integrin signaling. Science 285, 1028-1032.
Gingras, A. C., Raught, B. and Sonenberg, N. (2001). Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15, 807-826.
Glenney, J. R., Jr and Zokas, L. (1989). Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J. Cell Biol. 108, 2401-2408.[Abstract]
Gumbiner, B. M. (1992). Epithelial morphogenesis. Cell 69, 385-387.[Medline]
Gumienny, T. L., Brugnera, E., Tosello-Trampont, A. C., Kinchen, J. M., Haney, L. B., Nishiwaki, K., Walk, S. F., Nemergut, M. E., Macara, I. G., Francis, R. et al. (2001). CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 107, 27-41.[CrossRef][Medline]
Hagel, M., George, E. L., Kim, A., Tamimi, R., Opitz, S. L., Turner, C. E., Imamoto, A. and Thomas, S. M. (2002). The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22, 901-915.
Hall, H. G., Farson, D. A. and Bissell, M. J. (1982). Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc. Natl. Acad. Sci. USA 79, 4672-4676.
Han, X., Stewart, J. E., Jr, Bellis, S. L., Benveniste, E. N., Ding, Q., Tachibana, K., Grammer, J. R. and Gladson, C. L. (2001). TGF-beta1 up-regulates paxillin protein expression in malignant astrocytoma cells: requirement for a fibronectin substrate. Oncogene 20, 7976-7986.[CrossRef][Medline]
Hannigan, G. E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M. G., Radeva, G., Filmus, J., Bell, J. C. and Dedhar, S. (1996). Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379, 91-96.[CrossRef][Medline]
Hay, E. D. (1995). An overview of epithelio-mesenchymal transformation. Acta Anat. 154, 8-20.[Medline]
Herreros, L., Rodriguez-Fernandez, J. L., Brown, M. C., Alonso-Lebrero, J. L., Cabanas, C., Sanchez-Madrid, F., Longo, N., Turner, C. E. and Sanchez-Mateos, P. (2000). Paxillin localizes to the lymphocyte microtubule organizing center and associates with the microtubule cytoskeleton. J. Biol. Chem. 275, 26436-26440.
Kim, K., Lu, Z. and Hay, E. D. (2002). Direct evidence for a role of beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol. Int. 26, 463-476.[CrossRef][Medline]
Kim-Kaneyama, J., Shibanuma, M. and Nose, K. (2002). Transcriptional activation of the c-fos gene by a LIM protein, Hic-5. Biochem. Biophys. Res. Commun. 299, 360-365.[CrossRef][Medline]
Kinch, M. S. and Burridge, K. (1995). Altered adhesions in ras-transformed breast epithelial cells. Biochem. Soc. Trans. 23, 446-450.[Medline]
Kozak, M. (1987). An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Research 15, 8125-8148.[Abstract]
Lamorte, L., Rodrigues, S., Sangwan, V., Turner, C. E. and Park, M. (2003). Crk associates with a multimolecular Paxillin/GIT2/beta-PIX complex and promotes Rac-dependent relocalization of Paxillin to focal contacts. Mol. Biol. Cell 14, 2818-2831.
Lipsky, B. P., Beals, C. R. and Staunton, D. E. (1998). Leupaxin is a novel LIM domain protein that forms a complex with PYK2. J. Biol. Chem. 273, 11709-11713.
Lozano, E., Betson, M. and Braga, V. M. (2003). Tumor progression: Small GTPases and loss of cell-cell adhesion. BioEssays 25, 452-463.[CrossRef][Medline]
Mazaki, Y., Hashimoto, S. and Sabe, H. (1997). Monocyte cells and cancer cells express novel paxillin isoforms with different binding properties to focal adhesion proteins. J. Biol. Chem. 272, 7437-7444.
Mazaki, Y., Uchida, H., Hino, O., Hashimoto, S. and Sabe, H. (1998). Paxillin isoforms in mouse. Lack of the gamma isoform and developmentally specific beta isoform expression. J. Biol. Chem. 273, 22435-22441.
Mazaki, Y., Hashimoto, S., Okawa, K., Tsubouchi, A., Nakamura, K., Yagi, R., Yano, H., Kondo, A., Iwamatsu, A., Mizoguchi, A. et al. (2001). An ADP-ribosylation factor GTPase-activating protein Git2-short/KIAA0148 is involved in subcellular localization of paxillin and actin cytoskeletal organization. Mol. Biol. Cell 12, 645-662.
Mestayer, C., Blanchere, M., Jaubert, F., Dufour, B. and Mowszowicz, I. (2003). Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines. Prostate 56, 192-200.[CrossRef][Medline]
Miettinen, P. J., Ebner, R., Lopez, A. R. and Derynck, R. (1994). TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127, 2021-2036.[Abstract]
Mueller, S. C., Yeh, Y. and Chen, W. T. (1992). Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol. 119, 1309-1325.[Abstract]
Nakamura, K., Yano, H., Uchida, H., Hashimoto, S., Schaefer, E. and Sabe, H. (2000). Tyrosine phosphorylation of paxillin alpha is involved in temporospatial regulation of paxillin-containing focal adhesion formation and F-actin organization in motile cells. J. Biol. Chem. 275, 27155-27164.
Nikolopoulos, S. N. and Turner, C. E. (2000). Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J. Cell Biol. 151, 1435-1448.
Nikolopoulos, S. N. and Turner, C. E. (2001). Integrin-linked kinase (ILK) binding to paxillin LD1 motif regulates ILK localization to focal adhesions. J. Biol. Chem. 276, 23499-23505.
Nishiya, N., Iwabuchi, Y., Shibanuma, M., Cote, J. F., Tremblay, M. L. and Nose, K. (1999). Hic-5, a paxillin homologue, binds to the protein-tyrosine phosphatase PEST (PTP-PEST) through its LIM 3 domain. J. Biol. Chem. 274, 9847-9853.
Nishiya, N., Tachibana, K., Shibanuma, M., Mashimo, J. I. and Nose, K. (2001). Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol. Cell. Biol. 21, 5332-5345.
Nishiya, N., Shirai, T., Suzuki, W. and Nose, K. (2002). Hic-5 interacts with GIT1 with a different binding mode from paxillin. J. Biochem. 132, 279-289.[Abstract]
Nobes, C. D. and Hall, A. (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81, 53-62.[CrossRef][Medline]
Noren, N. K., Arthur, W. T. and Burridge, K. (2003). Cadherin engagement inhibits RhoA via p190RhoGAP. J. Biol. Chem. 278, 13615-13618.
Novak, A., Hsu, S. C., Leung-Hagesteijn, C., Radeva, G., Papkoff, J., Montesano, R., Roskelley, C., Grosschedl, R. and Dedhar, S. (1998). Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA 95, 4374-4379.
Pelletier, J. and Sonenberg, N. (1987). The involvement of mRNA secondary structure in protein synthesis. Biochem. Cell Biol. 65, 576-581.[Medline]
Persad, S., Troussard, A. A., McPhee, T. R., Mulholland, D. J. and Dedhar, S. (2001). Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell Biol. 153, 1161-1174.
Petit, V., Boyer, B., Lentz, D., Turner, C. E., Thiery, J. P. and Valles, A. M. (2000). Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J. Cell Biol. 148, 957-970.
Premont, R. T., Claing, A., Vitale, N., Perry, S. J. and Lefkowitz, R. J. (2000). The GIT family of ADP-ribosylation factor GTPase-activating proteins. Functional diversity of GIT2 through alternative splicing. J. Biol. Chem. 275, 22373-22380.
Reichmann, E., Schwarz, H., Deiner, E. M., Leitner, I., Eilers, M., Berger, J., Busslinger, M. and Beug, H. (1992). Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71, 1103-1116.[Medline]
Riedy, M. C., Brown, M. C., Molloy, C. J. and Turner, C. E. (1999). Activin A and TGF-beta stimulate phosphorylation of focal adhesion proteins and cytoskeletal reorganization in rat aortic smooth muscle cells. Exp. Cell Res. 251, 194-202.[CrossRef][Medline]
Rozengurt, E. (1995). Convergent signalling in the action of integrins, neuropeptides, growth factors and oncogenes. Cancer Surv. 24, 81-96.[Medline]
Sabe, H., Kurosaki, T., Takata, M. and Hanafusa, H. (1994). Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. Mol. Cell. Biol. 14, 7306-7313.[Abstract]
Saelman, E. U., Keely, P. J. and Santoro, S. A. (1995). Loss of MDCK cell alpha 2 beta 1 integrin expression results in reduced cyst formation, failure of hepatocyte growth factor/scatter factor-induced branching morphogenesis, and increased apoptosis. J. Cell Sci. 108, 3531-3540.
Salgia, R., Li, J. L., Lo, S. H., Brunkhorst, B., Kansas, G. S., Sobhany, E. S., Sun, Y., Pisick, E., Hallek, M., Ernst, T. et al. (1995). Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J. Biol. Chem. 270, 5039-5047.
Sanceau, J., Truchet, S. and Bauvois, B. (2003). Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. J. Biol. Chem. 278, 36537-36546.
Savagner, P. (2001). Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. BioEssays 23, 912-923.[CrossRef][Medline]
Schaller, M. D. and Parsons, J. T. (1995). pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol. Cell. Biol. 15, 2635-2645.[Abstract]
Schaller, M. D., Borgman, C. A. and Parsons, J. T. (1993). Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol. Cell. Biol. 13, 785-791.[Abstract]
Schwartz, M. A., Schaller, M. D. and Ginsberg, M. H. (1995). Integrins: emerging paradigms of signal transduction. Ann. Rev. Cell Dev. Biol. 11, 549-599.[CrossRef][Medline]
Shibanuma, M., Mashimo, J., Kuroki, T. and Nose, K. (1994). Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J. Biol. Chem. 269, 26767-26774.
Shibanuma, M., Satoh, H., Chida, K., Nose, K. and Mashimo, J. (2000). Genomic structure and chromosomal mapping of the mouse hic-5 gene that encodes a focal adhesion protein. Gene 249, 99-103.[CrossRef][Medline]
Somasiri, A., Howarth, A., Goswami, D., Dedhar, S. and Roskelley, C. D. (2001). Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J. Cell Sci. 114, 1125-1136.
Sonenberg, N., Hershey, J. W. B. and Mathews, M. (2000). Translational Control Of Gene Expression. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Sorenson, C. M. and Sheibani, N. (1999). Focal adhesion kinase, paxillin, and bcl-2: analysis of expression, phosphorylation, and association during morphogenesis. Dev. Dyn. 215, 371-382.[CrossRef][Medline]
Soriano, J. V., Pepper, M. S., Nakamura, T., Orci, L. and Montesano, R. (1995). Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells. J. Cell Sci. 108, 413-430.
Surin, B., Rouillard, D. and Bauvois, B. (2000). Loss of alpha5beta1-mediated adhesion of monocytic cells to fibronectin by interferons beta and gamma is associated with changes in actin and paxillin cytoskeleton. Hematol. J. 1, 172-180.[CrossRef][Medline]
Surin, B., Rouillard, D. and Bauvois, B. (2002). Interactions between human monocytes and fibronectin are suppressed by interferons beta and gamma, but not alpha: correlation with Rho-paxillin signaling. Int. J. Mol. Med. 10, 25-31.[Medline]
Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.[CrossRef][Medline]
Thomas, S. M., Hagel, M. and Turner, C. E. (1999). Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J. Cell Sci. 112, 181-190.
Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H. and Sabe, H. (2002). Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J. Cell Biol. 159, 673-683.
Tu, Y., Huang, Y., Zhang, Y., Hua, Y. and Wu, C. (2001). A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J. Cell Biol. 153, 585-598.
Tumbarello, D. A., Brown, M. C. and Turner, C. E. (2002). The paxillin LD motifs. FEBS Lett. 513, 114-118.[CrossRef][Medline]
Turner, C. E. (1991). Paxillin is a major phosphotyrosine-containing protein during embryonic development. J. Cell Biol. 115, 201-207.[Abstract]
Turner, C. E. (2000). Paxillin and focal adhesion signalling. Nat. Cell. Biol. 2, E231-E236.[CrossRef][Medline]
Turner, C. E. and Miller, J. T. (1994). Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region. J. Cell Sci. 107, 1583-1591.
Turner, C. E., Glenney, J. R., Jr and Burridge, K. (1990). Paxillin: a new vinculin-binding protein present in focal adhesions. J. Cell Biol. 111, 1059-1068.[Abstract]
Turner, C. E., Pietras, K. M., Taylor, D. S. and Molloy, C. J. (1995). Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J. Cell Sci. 108, 333-342.
Turner, C. E., Brown, M. C., Perrotta, J. A., Riedy, M. C., Nikolopoulos, S. N., McDonald, A. R., Bagrodia, S., Thomas, S. and Leventhal, P. S. (1999). Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: A role in cytoskeletal remodeling. J. Cell Biol. 145, 851-863.
Wade, R., Bohl, J. and Vande Pol, S. (2002). Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene 21, 96-107.[CrossRef][Medline]
Wang, Y. K., Wang, Y. H., Wang, C. Z., Sung, J. M., Chiu, W. T., Lin, S. H., Chang, Y. H. and Tang, M. J. (2003). Rigidity of collagen fibrils controls collagen gel-induced down-regulation of focal adhesion complex proteins mediated by alpha2beta1 integrin. J. Biol. Chem. 278, 21886-21892.
Weng, Z., Taylor, J. A., Turner, C. E., Brugge, J. S. and Seidel-Dugan, C. (1993). Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells. J. Biol. Chem. 268, 14956-14963.
West, K. A., Zhang, H., Brown, M. C., Nikolopoulos, S. N., Riedy, M. C., Horwitz, A. F. and Turner, C. E. (2001). The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J. Cell Biol. 154, 161-176.
Woods, A. J., Roberts, M. S., Choudhary, J., Barry, S. T., Mazaki, Y., Sabe, H., Morley, S. J., Critchley, D. R. and Norman, J. C. (2002). Paxillin associates with poly(A)-binding protein 1 at the dense endoplasmic reticulum and the leading edge of migrating cells. J. Biol. Chem. 277, 6428-6437.
Wozniak, M. A., Desai, R., Solski, P. A., Der, C. J. and Keely, P. J. (2003). ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J. Cell Biol. 163, 583-595.
Wu, C., Keightley, S. Y., Leung-Hagesteijn, C., Radeva, G., Coppolino, M., Goicoechea, S., McDonald, J. A. and Dedhar, S. (1998). Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J. Biol. Chem. 273, 528-536.
Xiong, W. C., Macklem, M. and Parsons, J. T. (1998). Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. J. Cell Sci. 111, 1981-1991.[Medline]
Yamaguchi, R., Maki, M., Hatanaka, M. and Sabe, H. (1994). Unphosphorylated and tyrosine-phosphorylated forms of a focal adhesion protein, paxillin, are substrates for calpain II in vitro: implications for the possible involvement of calpain II in mitosis-specific degradation of paxillin. FEBS Lett. 356, 114-116.[CrossRef][Medline]
Yano, H., Uchida, H., Hashimoto, S., Schaefer, E. and Sabe, H. (2000). Paxillin alpha and Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation. J. Biol. Chem. 275, 27155-27164.
Zegers, M. M., O'Brien, L. E., Yu, W., Datta, A. and Mostov, K. E. (2003). Epithelial polarity and tubulogenesis in vitro. Trends Cell. Biol. 13, 169-176.[CrossRef][Medline]
Zhang, J., Zhang, L. X., Meltzer, P. S., Barrett, J. C. and Trent, J. M. (2000). Molecular cloning of human Hic-5, a potential regulator involved in signal transduction and cellular senescence. Mol. Carcinog. 27, 177-183.[CrossRef][Medline]
Zutter, M. M., Santoro, S. A., Wu, J. E., Wakatsuki, T., Dickeson, S. K. and Elson, E. L. (1999). Collagen receptor control of epithelial morphogenesis and cell cycle progression. Am. J. Pathol. 155, 927-940.